直肠癌患者经肛门或腹腔镜行全直肠系膜切除术后的生活质量分析:一项回顾性队列研究

陈佳钰, 李玥, 陈帆, 李玉雪, 封士冬, 黄琦, 李大卫, 廖芝伟

  1. 1.复旦大学附属肿瘤医院大肠外科,复旦大学上海医学院肿瘤学系,上海 200032
    2.上海大学附属仁和医院普外科,上海 200431
  • 收稿日期:2024-10-16 修回日期:2024-12-09 出版日期:2025-04-30 发布日期:2025-05-16
  • 通信作者: 李大卫,廖芝伟
  • 作者简介:陈佳钰(ORCID: 0009-0008-5351-0553),硕士研究生;
    共同第一作者:李玥(ORCID: 0000-0003-4864-6188),上海大学附属仁和医院普外科主治医师。
  • 基金资助:
    上海市宝山区科学技术委员会医学卫生项目(21-E-26)

摘要/Abstract

摘要:

背景与目的:针对直肠癌经肛门全直肠系膜切除术(transanal total mesorectal excision,TaTME)术后患者生活质量的研究较少,缺乏循证医学证据。本研究旨在探讨与腹腔镜全直肠系膜切除术(laparoscopic total mesorectal excision,LaTME)相比,TaTME对患者术后生活质量的影响。方法:对2019年9月—2022年9月上海大学附属仁和医院及复旦大学附属肿瘤医院收治的行LaTME的直肠癌患者及同期行TaTME的直肠癌患者的临床及病理学资料进行对比分析,在术后1年时完成调查问卷:癌症患者生活质量量表(European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30,EORCT QLQ-C30)、低位前切除综合征(low anterior resection syndrome,LARS)评价量表、国际前列腺症状评分(International Prostate Symptom Score,IPSS)、广泛性焦虑量表(Generalized Anxiety Disorder-7,GAD-7)和抑郁自评量表(Patient Health Questionnaire-9,PHQ-9),对问卷结果进行比较分析。本研究通过上海市宝山区仁和医院伦理委员会的审查。本研究严格遵循《加强流行病学中观察性研究报告质量》(Strengthening the Reporting of Observational Studies in Epidemiology,STROBE)指南中的各项条目。结果:本研究纳入77例患者(TaTME组39例和LaTME组38例),两组患者在性别、年龄、肿瘤距肛缘距离、肿瘤分期、术前新辅助治疗方案等方面差异均无统计学意义。EORCT QLQ-C30结果表明两组患者的生活质量相当,但TaTME组失眠症状更严重(P=0.020)。两组在LARS严重程度和评分之间差异无统计学意义。TaTME组在水样便失禁和大便簇集两个项目中表现出更好的功能(P=0.007,P=0.004)。此外,两组在IPSS、抑郁和焦虑程度上均具有可比性。结论:接受TaTME或LaTME的患者表现出相似的肛门功能、排尿功能、生活质量和心理健康结果,从术后生活质量方面而言,TaTME技术是腹腔镜手术的安全替代方案。

关键词: 经肛门全直肠系膜切除术, 直肠癌, 生活质量, 器官功能, 心理健康

Abstract:

Background and purpose: There are few studies on the quality of life after transanal total mesorectal excision (TaTME) for rectal cancer, and there is a lack of evidence-based research. This study aimed to evaluate the impact of TaTME in comparison to laparoscopic total mesorectal excision (LaTME) on postoperative quality of life in patients. Methods: A retrospective analysis was conducted on clinical and pathological data from rectal cancer patients who underwent LaTME and TaTME between September 2019 and September 2022 at Renhe Hospital, Baoshan District, Shanghai, and Fudan University Shanghai Cancer Center. All the patients completed a set of validated questionnaires one year postoperatively, including the EORCT QLQ-C30, Low Anterior Resection Syndrome (LARS) score, International Prostate Symptom Score (IPSS), Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9). Comparative analysis of these survey results was performed.The study was approved by the Ethics Committee of Renhe Hospital, Baoshan District, Shanghai. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was followed for this study. Results: A total of 39 patients in the TaTME group and 38 patients in the LaTME group were included. There were no statistically significant differences between two groups regarding demographic variables such as gender and age, as well as clinical factors including tumor distance from the anal verge, tumor stage, and preoperative neoadjuvant treatment protocols. Analysis of EORCT QLQ-C30 results indicated equivalent overall quality of life between the two groups; however, the TaTME group reported significantly more severe insomnia (P=0.020). No significant differences were observed in LARS severity or total scores between the groups, though the TaTME group demonstrated superior functional outcomes in terms of incontinence for liquid stools and clustering of stools (P=0.007, P=0.004). Additionally, both groups exhibited comparable results in IPSS, and levels of depression and anxiety. Conclusion: The findings suggest that TaTME and LaTME yield similar outcomes in terms of anal and urinary function, overall quality of life, and psychological health, indicating that it is a viable and safe alternative to LaTME in terms of postoperative quality of life.

Key words: Transanal total mesorectal excision, Rectal cancer, Quality of life, Organ function, Psychological health

相关文章

[1] 宋丹, 柴亚欣, 葛延平. 直肠癌DCE-MRI定量分析参数与微血管生成的相关性分析[J]. 中国癌症杂志, 2025, 35(3): 320-325.
[2] 黄浩哲, 陈红, 郑德重, 陈超, 王英, 许立超, 王耀辉, 何新红, 杨媛媛, 李文涛. 基于CT的影像组学诺模图预测结直肠癌肺转移射频消融后的局部肿瘤进展[J]. 中国癌症杂志, 2024, 34(9): 857-872.
[3] 伍雯, 张若昕, 翁俊勇, 马延磊, 蔡国响, 李心翔, 杨永志. 探索阳性淋巴结比率在ypⅢ期结直肠癌患者中的预后价值及预测模型的建立[J]. 中国癌症杂志, 2024, 34(9): 873-880.
[4] 严研, 周立庆, 夏建洪, 马婷婷. TCF7转录激活MACC1调节有氧糖酵解促进直肠癌奥沙利铂耐药[J]. 中国癌症杂志, 2024, 34(8): 715-725.
[5] 葛祖荫, 宋坤, 林云霄, 钟烨凌, 郝敬铎. 循环肿瘤细胞FCGBP和BIGH3作为结直肠癌潜在生物标志物的可行性研究[J]. 中国癌症杂志, 2024, 34(8): 745-752.
[6] 刘帅, 张凯, 张晓青, 栾巍. 派安普利单抗联合安罗替尼和化疗围手术期治疗局部进展期胃癌的探索性研究[J]. 中国癌症杂志, 2024, 34(7): 659-668.
[7] 翁俊勇, 叶紫岚, 张若昕, 刘琪, 李心翔. 探究不良病理学特征数量对Ⅰ~Ⅲ期结直肠癌复发风险分层的指导作用:对9 875例病例的回顾性队例研究[J]. 中国癌症杂志, 2024, 34(6): 527-536.
[8] 唐楠, 黄慧霞, 刘晓健. 利用单细胞测序和转录组测序建立结直肠癌免疫细胞的9基因预后模型[J]. 中国癌症杂志, 2024, 34(6): 548-560.
[9] 张若昕, 叶紫岚, 翁俊勇, 李心翔. 高龄与Ⅱ期结直肠癌患者预后不良的相关性研究[J]. 中国癌症杂志, 2024, 34(5): 485-492.
[10] 陆悦, 卢仁泉, 张杰, 郑慧. 联合凝血功能指标在结直肠癌患者化疗后高凝状态监测中的应用价值[J]. 中国癌症杂志, 2024, 34(3): 278-285.
[11] 刘志昱, 徐栋, 陈西昊, 李纪鹏. 局部进展期直肠癌新辅助放化疗后肿瘤退缩的影响因素分析及预测模型构建[J]. 中国癌症杂志, 2024, 34(2): 191-200.
[12] 李军, 陆亭伟, 方旭前. MSI-H/dMMR对BRAF V600E突变型的手术可切除结直肠癌患者的临床病理学特征及预后的影响[J]. 中国癌症杂志, 2024, 34(11): 1061-1066.
[13] 吴志柏, 许桂琴, 张力, 杨兆娟, 刘昀, 焦琨, 陈泽宏, 许晨, 左佑, 郑宁倩, 叶志谦, 刘永忠. KCMF1促进结直肠癌细胞增殖和NF-κB信号转导的机制研究[J]. 中国癌症杂志, 2024, 34(11): 987-997.
[14] 储亚娟, 张蕾, 李云海, 罗伟明, 张静, 莫晓晨, 马金利. 探讨氨磷汀对局部晚期直肠癌新辅助放疗同期伊立替康化疗的减毒作用:对154例病例的回顾性队列研究[J]. 中国癌症杂志, 2024, 34(10): 957-965.
[15] 张少华, 黎哲宁, 王薇, 卫奕凡, 洪永刚, 郝立强. KRAS突变结直肠癌相关治疗的研究进展[J]. 中国癌症杂志, 2024, 34(10): 979-986.